News & Updates

Expectant mums with anorexia nervosa at increased risk of adverse pregnancy outcomes

06 Dec 2023

The presence of anorexia nervosa during pregnancy may contribute to elevated risks of clinically important adverse pregnancy outcomes, with a significant proportion of the excess risk due to an underweight prepregnancy body mass index (BMI) or gestational weight gain below the recommendation, as shown in a study.

Expectant mums with anorexia nervosa at increased risk of adverse pregnancy outcomes

06 Dec 2023

Prepregnancy energy drink consumption may raise gestational hypertension risk

05 Dec 2023

Women who consume energy drinks before pregnancy may potentially be at increased risk of gestational hypertension, as reported in a study.

Prepregnancy energy drink consumption may raise gestational hypertension risk

05 Dec 2023

HPV self-sampling with isothermal amplification detection may become part of cervical cancer screening

05 Dec 2023 by

A prospective study in women attending a colposcopy clinic in Hong Kong supports the use of self-sampling with an isothermal amplification (AmpFire)–based assay for human papillomavirus (HPV) detection in cervical cancer screening, showing substantial agreement with clinician sampling using either the AmpFire-based or polymerase chain reaction (PCR)–based reference assay.

HPV self-sampling with isothermal amplification detection may become part of cervical cancer screening

05 Dec 2023

Fezolinetant superior to other non-HTs at reducing bothersome VMS due to menopause

05 Dec 2023

Treatment with fezolinetant 45 mg outperforms other nonhormone therapies (non-HTs) in terms of minimizing the frequency of moderate-to-severe vasomotor symptoms (VMS) in women undergoing menopause, according to a study from the US.

Fezolinetant superior to other non-HTs at reducing bothersome VMS due to menopause

05 Dec 2023

HPV ctDNA testing identifies cervical cancer patients at high risk of relapse after CRT

05 Dec 2023 by

Detection of human papilloma virus (HPV) circulating tumour DNA (ctDNA) after completion of chemoradiation therapy (CRT) is independently associated with inferior progression-free survival (PFS) in patients with cervical cancer, a prospective multicentre study has shown. According to the researchers, early HPV ctDNA testing after CRT can identify patients at high risk of relapse.

HPV ctDNA testing identifies cervical cancer patients at high risk of relapse after CRT

05 Dec 2023

Gestational diabetes history ups NAFLD risk in women

04 Dec 2023

Women with a history of gestational diabetes mellitus (GDM) are at higher risk of developing nonalcoholic fatty liver disease (NAFLD), suggests a recent study.

Gestational diabetes history ups NAFLD risk in women

04 Dec 2023

In utero cannabis exposure tied to adverse neonatal health outcomes

01 Dec 2023

Maternal cannabis use during pregnancy appears to contribute to increased risk of adverse neonatal health outcomes, including low birth weight (LBW) and small for gestational age (SGA), as reported in a study.

In utero cannabis exposure tied to adverse neonatal health outcomes

01 Dec 2023

Psychological burden high in women with threatened miscarriage

30 Nov 2023 by

A substantial proportion of women with threatened miscarriage show distress as well as depressive and anxiety symptoms, researchers from the University of Hong Kong have reported.

Psychological burden high in women with threatened miscarriage

30 Nov 2023

Pre-eclampsia ups venous thromboembolism risk during pregnancy

29 Nov 2023

Women with a history of pre-eclampsia are at increased risk of venous thromboembolism during pregnancy, according to a study.

Pre-eclampsia ups venous thromboembolism risk during pregnancy

29 Nov 2023

Self-monitoring improves postpartum BP control in women with hypertensive pregnancy

27 Nov 2023 by

Empowering mums to self-monitor their blood pressure (BP) with a physician-guided titration of antihypertensive medications helps lower postpartum BP level after a pregnancy complicated by hypertension, as shown in the POP-HT trial.

Self-monitoring improves postpartum BP control in women with hypertensive pregnancy

27 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Expectant mums with anorexia nervosa at increased risk of adverse pregnancy outcomes

Expectant mums with anorexia nervosa at increased risk of adverse pregnancy outcomes

Prepregnancy energy drink consumption may raise gestational hypertension risk

Prepregnancy energy drink consumption may raise gestational hypertension risk

HPV self-sampling with isothermal amplification detection may become part of cervical cancer screening

HPV self-sampling with isothermal amplification detection may become part of cervical cancer screening

Fezolinetant superior to other non-HTs at reducing bothersome VMS due to menopause

Fezolinetant superior to other non-HTs at reducing bothersome VMS due to menopause

HPV ctDNA testing identifies cervical cancer patients at high risk of relapse after CRT

HPV ctDNA testing identifies cervical cancer patients at high risk of relapse after CRT

Gestational diabetes history ups NAFLD risk in women

Gestational diabetes history ups NAFLD risk in women

In utero cannabis exposure tied to adverse neonatal health outcomes

In utero cannabis exposure tied to adverse neonatal health outcomes

Psychological burden high in women with threatened miscarriage

Psychological burden high in women with threatened miscarriage

Pre-eclampsia ups venous thromboembolism risk during pregnancy

Pre-eclampsia ups venous thromboembolism risk during pregnancy

Self-monitoring improves postpartum BP control in women with hypertensive pregnancy

Self-monitoring improves postpartum BP control in women with hypertensive pregnancy